Even though disease-free survival is not statistically significant (log-rank (Mantel-Cox) = 2.325, p = 0.127), there is a clear trend that patients with tumors with low COX-2 immunostaining have longer disease-free survival and those with tumors with high COX-2 immunostaining have shorter disease-free survival ( Figure 3 ). 4.
← all excerpts
Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis.
1
—
—